ESR1 and breast cancer: The anti-breast cancer properties of Ole have been repeatedly confirmed by vast number of studies on both estrogen receptor (ER)-positive and ER-negative breast cancer cells, demonstrating the antiproliferative and proapoptotic effects of this secoiridoid compound [205,206].